Is MIO-RSA Noninferior to BIO-RSA When it Comes to Mechanical Implant Stability?

Recruiting N/A Interventional Study
Arthroplasty Complications Shoulder Osteoarthritis
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
45 – 80
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
20 (estimated)
Sponsor
Lovisenberg Diakonale Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This clinical trial will investigate whether metallic lateralization in reverse shoulder arthroplasty is as stable as bony lateralization during the first two postsurgical years, measured with CT-based motion analysis (CTMA).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Eligible for primary RSA due to OA, massive RC tear, failed RC repair or post-instability osteoarthritis * massive glenoid medialization * Able to read or write Norwegian Exclusion Criteria: * Severe osteoporosis * Osteonecrosis of the humeral head * Dementia * Poor deltoid …
Contacts

Christian Owesen, PhD

+4790515843

cow@lds.no

CONTACT

Hanne Fuglø, MPTh

+4790524172

hanne.fuglo@lds.no

CONTACT